selected publications
-
Geriatric syndromes in 2-year, progression-free survivors among older recipients of allogeneic hematopoietic cell transplantation.
Bone marrow transplantation.
2020
Letter
GET IT
Times cited: 4 -
Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation.
The Journal of clinical investigation.
2020
Academic Article
GET IT
Times cited: 176 - Favorable long-term outcomes of hematopoietic stem cell transplantation for CMML with myeloablative conditioning, anti-thymocyte globulin, and CD34+ selected graft. Bone marrow transplantation. 2019 Letter GET IT
-
Ex Vivo T Cell-Depleted Hematopoietic Stem Cell Transplantation for Adult Patients with Acute Myelogenous Leukemia in First and Second Remission: Long-Term Disease-Free Survival with a Significantly Reduced Risk of Graft-versus-Host Disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2019
Academic Article
GET IT
Times cited: 21 -
Reconstitution of the gut microbiota of antibiotic-treated patients by autologous fecal microbiota transplant.
Science translational medicine.
2018
Academic Article
GET IT
Times cited: 257 -
A protective Langerhans cell-keratinocyte axis that is dysfunctional in photosensitivity.
Science translational medicine.
2018
Academic Article
GET IT
Times cited: 47 -
Primary T Cells from Cutaneous T-cell Lymphoma Skin Explants Display an Exhausted Immune Checkpoint Profile.
Cancer immunology research.
2018
Academic Article
GET IT
Times cited: 74 -
Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndrome: Comparison of Outcomes between CD34+ Selected and Unmodified Hematopoietic Stem Cell Transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2018
Academic Article
GET IT
Times cited: 19 -
T Cell Depletion as an Alternative Approach for Patients 55 Years or Older Undergoing Allogeneic Stem Cell Transplantation as Curative Therapy for Hematologic Malignancies.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2017
Academic Article
GET IT
Times cited: 8 -
A Chemotherapy-Only Regimen of Busulfan, Melphalan, and Fludarabine, and Rabbit Antithymocyte Globulin Followed by Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplantations for the Treatment of Myeloid Malignancies.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2017
Academic Article
GET IT
Times cited: 6 -
Early recovery of T-cell function predicts improved survival after T-cell depleted allogeneic transplant.
Leukemia & lymphoma.
2017
Academic Article
GET IT
Times cited: 50 -
Ex Vivo CD34+-Selected T Cell-Depleted Peripheral Blood Stem Cell Grafts for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Leukemia and Myelodysplastic Syndrome Is Associated with Low Incidence of Acute and Chronic Graft-versus-Host Disease and High Treatment Response.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2016
Academic Article
GET IT
Times cited: 33 -
Human Dendritic Cells Mitigate NK-Cell Dysfunction Mediated by Nonselective JAK1/2 Blockade.
Cancer immunology research.
2016
Academic Article
GET IT
Times cited: 30 -
Hematopoietic Cell Transplantation Comorbidity Index Predicts Outcomes in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes Receiving CD34+ Selected Grafts for Allogeneic Hematopoietic Cell Transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2016
Academic Article
GET IT
Times cited: 22 -
Second Allogeneic Stem Cell Transplantation for Acute Leukemia Using a Chemotherapy-Only Cytoreduction with Clofarabine, Melphalan, and Thiotepa.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2016
Academic Article
GET IT
Times cited: 10 -
Phase II Study of Haploidentical Natural Killer Cell Infusion for Treatment of Relapsed or Persistent Myeloid Malignancies Following Allogeneic Hematopoietic Cell Transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2016
Academic Article
GET IT
Times cited: 114 -
T-cell Exhaustion in Multiple Myeloma Relapse after Autotransplant: Optimal Timing of Immunotherapy.
Cancer immunology research.
2015
Academic Article
GET IT
Times cited: 155 -
Robust Vaccine Responses in Adult and Pediatric Cord Blood Transplantation Recipients Treated for Hematologic Malignancies.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2015
Academic Article
GET IT
Times cited: 31 -
High Disease-Free Survival with Enhanced Protection against Relapse after Double-Unit Cord Blood Transplantation When Compared with T Cell-Depleted Unrelated Donor Transplantation in Patients with Acute Leukemia and Chronic Myelogenous Leukemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2015
Academic Article
GET IT
Times cited: 37 -
Association between Nondominant Unit Total Nucleated Cell Dose and Engraftment in Myeloablative Double-Unit Cord Blood Transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2015
Academic Article
GET IT
Times cited: 8 -
CD34-Selected Hematopoietic Stem Cell Transplants Conditioned with Myeloablative Regimens and Antithymocyte Globulin for Advanced Myelodysplastic Syndrome: Limited Graft-versus-Host Disease without Increased Relapse.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2015
Academic Article
GET IT
Times cited: 44 -
Intensified Mycophenolate Mofetil Dosing and Higher Mycophenolic Acid Trough Levels Reduce Severe Acute Graft-versus-Host Disease after Double-Unit Cord Blood Transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2015
Academic Article
GET IT
Times cited: 32 -
Phenotypic and functional activation of hyporesponsive KIRnegNKG2Aneg human NK-cell precursors requires IL12p70 provided by Poly(I:C)-matured monocyte-derived dendritic cells.
Cancer immunology research.
2014
Academic Article
GET IT
Times cited: 5 -
Frequent human herpesvirus-6 viremia but low incidence of encephalitis in double-unit cord blood recipients transplanted without antithymocyte globulin.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2014
Academic Article
GET IT
Times cited: 42 -
Langerhans-type and monocyte-derived human dendritic cells have different susceptibilities to mRNA electroporation with distinct effects on maturation and activation: implications for immunogenicity in dendritic cell-based immunotherapy.
Journal of translational medicine.
2013
Academic Article
GET IT
Times cited: 16 -
A novel reduced-intensity conditioning regimen induces a high incidence of sustained donor-derived neutrophil and platelet engraftment after double-unit cord blood transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2013
Academic Article
GET IT
Times cited: 56 -
Graft-versus-host disease after double-unit cord blood transplantation has unique features and an association with engrafting unit-to-recipient HLA match.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2013
Academic Article
GET IT
Times cited: 58 -
Recombinant human interleukin-7 (CYT107) promotes T-cell recovery after allogeneic stem cell transplantation.
Blood.
2012
Academic Article
GET IT
Times cited: 141 -
T cell-depleted stem cell transplantation for adults with high-risk acute lymphoblastic leukemia: long-term survival for patients in first complete remission with a decreased risk of graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2012
Academic Article
GET IT
Times cited: 37 -
Innate immune response of human plasmacytoid dendritic cells to poxvirus infection is subverted by vaccinia E3 via its Z-DNA/RNA binding domain.
PloS one.
2012
Academic Article
GET IT
Times cited: 27 -
Human Langerhans cells use an IL-15R-α/IL-15/pSTAT5-dependent mechanism to break T-cell tolerance against the self-differentiation tumor antigen WT1.
Blood.
2012
Academic Article
GET IT
Times cited: 44 -
Long-term survival in patients with peripheral T-cell non-Hodgkin lymphomas after allogeneic hematopoietic stem cell transplant.
Leukemia & lymphoma.
2012
Academic Article
GET IT
Times cited: 35 -
Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation.
Blood.
2011
Academic Article
GET IT
Times cited: 351 -
Effect of educational components and strategies associated with insulin pump therapy: a systematic review.
International journal of evidence-based healthcare.
2011
Information Resource
GET IT
Times cited: 12 -
Anti-IL6-receptor-alpha (tocilizumab) does not inhibit human monocyte-derived dendritic cell maturation or alloreactive T-cell responses.
Blood.
2011
Academic Article
GET IT
Times cited: 34 -
Janus kinase-2 inhibition induces durable tolerance to alloantigen by human dendritic cell-stimulated T cells yet preserves immunity to recall antigen.
Blood.
2011
Academic Article
GET IT
Times cited: 78 -
Peptide-loaded Langerhans cells, despite increased IL15 secretion and T-cell activation in vitro, elicit antitumor T-cell responses comparable to peptide-loaded monocyte-derived dendritic cells in vivo.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2011
Academic Article
GET IT
Times cited: 67 -
Reduced late mortality risk contributes to similar survival after double-unit cord blood transplantation compared with related and unrelated donor hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2011
Academic Article
GET IT
Times cited: 66 -
T cell-depleted unrelated donor stem cell transplantation provides favorable disease-free survival for adults with hematologic malignancies.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2011
Academic Article
GET IT
Times cited: 67 - Tregs served sunny-side up. Blood. 2010 Article GET IT
-
Availability of cord blood extends allogeneic hematopoietic stem cell transplant access to racial and ethnic minorities.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2010
Academic Article
GET IT
Times cited: 131 -
NCI First International Workshop on The Biology, Prevention and Treatment of Relapse after Allogeneic Hematopoietic Cell Transplantation: report from the committee on prevention of relapse following allogeneic cell transplantation for hematologic malignancies.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2010
Information Resource
GET IT
Times cited: 45 -
Chronic kidney disease, thrombotic microangiopathy, and hypertension following T cell-depleted hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2010
Academic Article
GET IT
Times cited: 69 -
Second-line age-adjusted International Prognostic Index in patients with advanced non-Hodgkin lymphoma after T-cell depleted allogeneic hematopoietic SCT.
Bone marrow transplantation.
2010
Academic Article
GET IT
Times cited: 21 -
Fourth complete remission with immunosuppression withdrawal and irinotecan after both autologous and allogeneic transplants for diffuse large B cell lymphoma.
Leukemia & lymphoma.
2009
Letter
GET IT
Times cited: 3 -
Cord blood units with low CD34+ cell viability have a low probability of engraftment after double unit transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2009
Academic Article
GET IT
Times cited: 101 -
Pre-engraftment syndrome after double-unit cord blood transplantation: a distinct syndrome not associated with acute graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2009
Academic Article
GET IT
Times cited: 49 -
Distinct responses of human monocyte subsets to Aspergillus fumigatus conidia.
Journal of immunology (Baltimore, Md. : 1950).
2009
Academic Article
GET IT
Times cited: 64 -
Priming of protective T cell responses against virus-induced tumors in mice with human immune system components.
The Journal of experimental medicine.
2009
Academic Article
GET IT
Times cited: 248 -
Indoleamine 2,3-dioxygenase-expressing mature human monocyte-derived dendritic cells expand potent autologous regulatory T cells.
Blood.
2009
Academic Article
GET IT
Times cited: 228 -
Human liver dendritic cells promote T cell hyporesponsiveness.
Journal of immunology (Baltimore, Md. : 1950).
2009
Academic Article
GET IT
Times cited: 186 -
Response to pneumococcal (PNCRM7) and haemophilus influenzae conjugate vaccines (HIB) in pediatric and adult recipients of an allogeneic hematopoietic cell transplantation (alloHCT).
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2008
Academic Article
GET IT
Times cited: 60 -
Sirolimus (rapamycin) induced proteinuria in a patient undergoing allogeneic hematopoietic stem cell transplant.
Transplantation.
2008
Article
GET IT
Times cited: 3 -
Transplantation in remission improves the disease-free survival of patients with advanced myelodysplastic syndromes treated with myeloablative T cell-depleted stem cell transplants from HLA-identical siblings.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2008
Academic Article
GET IT
Times cited: 59 -
CD32B is highly expressed on clonal plasma cells from patients with systemic light-chain amyloidosis and provides a target for monoclonal antibody-based therapy.
Blood.
2008
Academic Article
GET IT
Times cited: 38 -
Fludarabine-based conditioning secures engraftment of second hematopoietic stem cell allografts (HSCT) in the treatment of initial graft failure.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2007
Academic Article
GET IT
Times cited: 38 -
Scalable expansion of potent genetically modified human langerhans cells in a closed system for clinical applications.
Journal of immunotherapy (Hagerstown, Md. : 1997).
2007
Academic Article
GET IT
Times cited: 6 -
T cell depleted stem-cell transplantation for adults with hematologic malignancies: sustained engraftment of HLA-matched related donor grafts without the use of antithymocyte globulin.
Blood.
2007
Academic Article
GET IT
Times cited: 103 -
Colonization, bloodstream infection, and mortality caused by vancomycin-resistant enterococcus early after allogeneic hematopoietic stem cell transplant.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2007
Academic Article
GET IT
Times cited: 153 -
Intravenous busulfan and melphalan, tacrolimus, and short-course methotrexate followed by unmodified HLA-matched related or unrelated hematopoietic stem cell transplantation for the treatment of advanced hematologic malignancies.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2007
Academic Article
GET IT
Times cited: 24 -
Immunogenicity of recombinant hepatitis B vaccine (rHBV) in recipients of unrelated or related allogeneic hematopoietic cell (HC) transplants.
Blood.
2006
Academic Article
GET IT
Times cited: 61 -
Langerhans-type dendritic cells genetically modified to express full-length antigen optimally stimulate CTLs in a CD4-dependent manner.
Journal of immunology (Baltimore, Md. : 1950).
2006
Academic Article
GET IT
Times cited: 6 -
In vitro expansion of Ag-specific T cells by HLA-A*0201-transfected K562 cells for immune monitoring.
Cytotherapy.
2006
Academic Article
GET IT
Times cited: 10 -
Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions.
The Journal of clinical investigation.
2005
Academic Article
GET IT
Times cited: 310 -
Langerhans cells derived from genetically modified human CD34+ hemopoietic progenitors are more potent than peptide-pulsed Langerhans cells for inducing antigen-specific CD8+ cytolytic T lymphocyte responses.
Journal of immunology (Baltimore, Md. : 1950).
2005
Academic Article
GET IT
Times cited: 17 -
Mature myeloid dendritic cell subsets have distinct roles for activation and viability of circulating human natural killer cells.
Blood.
2004
Academic Article
GET IT
Times cited: 97 -
Mature human Langerhans cells derived from CD34+ hematopoietic progenitors stimulate greater cytolytic T lymphocyte activity in the absence of bioactive IL-12p70, by either single peptide presentation or cross-priming, than do dermal-interstitial or monocyte-derived dendritic cells.
Journal of immunology (Baltimore, Md. : 1950).
2004
Academic Article
GET IT
Times cited: 140 -
Infection of mature monocyte-derived dendritic cells with human cytomegalovirus inhibits stimulation of T-cell proliferation via the release of soluble CD83.
Blood.
2004
Academic Article
GET IT
Times cited: 131 -
Predominant autoantibody production by early human B cell precursors.
Science (New York, N.Y.).
2003
Academic Article
GET IT
Times cited: 1373 -
Differential CD52 expression by distinct myeloid dendritic cell subsets: implications for alemtuzumab activity at the level of antigen presentation in allogeneic graft-host interactions in transplantation.
Blood.
2002
Academic Article
GET IT
Times cited: 104 -
Direct evidence for new T-cell generation by patients after either T-cell-depleted or unmodified allogeneic hematopoietic stem cell transplantations.
Blood.
2002
Academic Article
GET IT
Times cited: 148 -
Expression of a functional eotaxin (CC chemokine ligand 11) receptor CCR3 by human dendritic cells.
Journal of immunology (Baltimore, Md. : 1950).
2002
Academic Article
GET IT
Times cited: 53 -
Identification of poor prognostic features among patients requiring mechanical ventilation after hematopoietic stem cell transplantation.
Blood.
2001
Academic Article
GET IT
Times cited: 91 - Dendritic cells as immunologic adjuvants for the treatment of cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2000 Editorial Article GET IT
-
Paucity of functional T-cell memory to melanoma antigens in healthy donors and melanoma patients.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2000
Academic Article
GET IT
Times cited: 33 -
Circulating human B cells that express surrogate light chains and edited receptors.
Nature immunology.
2000
Academic Article
GET IT
Times cited: 99 -
Retrovirally transduced mouse dendritic cells require CD4+ T cell help to elicit antitumor immunity: implications for the clinical use of dendritic cells.
Journal of immunology (Baltimore, Md. : 1950).
2000
Academic Article
GET IT
Times cited: 58 -
Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation: effect of patient age and donor leukocyte infusions.
Blood.
1999
Academic Article
GET IT
Times cited: 387 -
T-cell-depleted allogeneic bone marrow transplantation as postremission therapy for acute myelogenous leukemia: freedom from relapse in the absence of graft-versus-host disease.
Blood.
1998
Academic Article
GET IT
Times cited: 180 -
Retrovirally transduced human dendritic cells express a normal phenotype and potent T-cell stimulatory capacity.
Blood.
1997
Academic Article
GET IT
Times cited: 70 -
Risk of extramedullary relapse following allogeneic bone marrow transplantation for acute myelogenous leukemia with leukemia cutis.
Bone marrow transplantation.
1997
Academic Article
GET IT
Times cited: 39 -
The hematopoietic development of dendritic cells: a distinct pathway for myeloid differentiation.
Stem cells (Dayton, Ohio).
1996
Information Resource
GET IT
Times cited: 77 -
Dendritic cells and macrophages can mature independently from a human bone marrow-derived, post-colony-forming unit intermediate.
Blood.
1996
Academic Article
GET IT
Times cited: 200 -
Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity.
The Journal of experimental medicine.
1996
Article
GET IT
Times cited: 289 -
Identification of dendritic cell colony-forming units among normal human CD34+ bone marrow progenitors that are expanded by c-kit-ligand and yield pure dendritic cell colonies in the presence of granulocyte/macrophage colony-stimulating factor and tumor necrosis factor alpha.
The Journal of experimental medicine.
1995
Academic Article
GET IT
Times cited: 272 -
Telomerase activity in normal and malignant hematopoietic cells.
Proceedings of the National Academy of Sciences of the United States of America.
1995
Academic Article
GET IT
Times cited: 728 -
Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease.
Blood.
1995
Academic Article
GET IT
Times cited: 675 -
Expansion of immunostimulatory dendritic cells among the myeloid progeny of human CD34+ bone marrow precursors cultured with c-kit ligand, granulocyte-macrophage colony-stimulating factor, and TNF-alpha.
Journal of immunology (Baltimore, Md. : 1950).
1995
Academic Article
GET IT
Times cited: 320 -
Hyperfractionated total lymphoid irradiation and cyclophosphamide for preparation of previously transfused patients undergoing HLA-identical marrow transplantation for severe aplastic anemia.
International journal of radiation oncology, biology, physics.
1994
Academic Article
GET IT
Times cited: 13 -
Small amounts of superantigen, when presented on dendritic cells, are sufficient to initiate T cell responses.
The Journal of experimental medicine.
1993
Academic Article
GET IT
Times cited: 132 -
High-dose UV-B radiation alters human dendritic cell costimulatory activity but does not allow dendritic cells to tolerize T lymphocytes to alloantigen in vitro.
Blood.
1993
Academic Article
GET IT
Times cited: 41 -
The B7/BB1 antigen provides one of several costimulatory signals for the activation of CD4+ T lymphocytes by human blood dendritic cells in vitro.
The Journal of clinical investigation.
1992
Academic Article
GET IT
Times cited: 280 -
New technology for the depletion of T cells from soybean lectin agglutinated, HLA-matched bone marrow grafts for leukemia: initial laboratory and clinical results.
Progress in clinical and biological research.
1992
Academic Article
GET IT
Times cited: 8 -
Dendritic cells stimulate primary human cytolytic lymphocyte responses in the absence of CD4+ helper T cells.
The Journal of experimental medicine.
1990
Academic Article
GET IT
Times cited: 198 -
Accessory cell requirements for the mixed-leukocyte reaction and polyclonal mitogens, as studied with a new technique for enriching blood dendritic cells.
Cellular immunology.
1988
Academic Article
GET IT
Times cited: 107 -
Direct activation of CD8+ cytotoxic T lymphocytes by dendritic cells.
The Journal of experimental medicine.
1987
Academic Article
GET IT
Times cited: 218 -
Mononuclear phagocytes as targets for cytolytic T lymphocytes.
Journal of immunological methods.
1987
Academic Article
GET IT
Times cited: 5